<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Amicar (<z:chebi fb="0" ids="16586">epsilon-aminocaproic acid</z:chebi>) has been used in patients with <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> to promote clotting </plain></SENT>
<SENT sid="1" pm="."><plain>However, <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> has been reported in various vascular compartments following its use </plain></SENT>
<SENT sid="2" pm="."><plain>The authors describe 2 patients who had cerebral angiography after Amicar therapy and demonstrated <z:mp ids='MP_0005048'>thrombosis</z:mp> unrelated to vascular spasm or technical complications of angiography </plain></SENT>
<SENT sid="3" pm="."><plain>Careful screening is needed in patients treated with Amicar to determine if an increased risk of <z:mp ids='MP_0005048'>thrombosis</z:mp> exists </plain></SENT>
</text></document>